Cargando…
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
The treatment of chronic hepatitis B is in constant evolution. Interferon, the first agent licensed for chronic hepatitis B treatment, has been superseded by the growing popularity of nucleoside/nucleotide analogues (NA). However, resistance to these agents is a major challenge. Newer NAs, such as e...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Current Science Inc.
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210946/ https://www.ncbi.nlm.nih.gov/pubmed/22131901 http://dx.doi.org/10.1007/s11901-011-0109-z |